ClinicalTrials.gov
public full text
Public Domain
n-3 PUFA for Vascular Cognitive Aging
alzheimer-s-diseasecognitive-declineendothelial-dysfunctionexecutive-functionmripreventionwhite-matter
Brain scans can help identify changes that appear to increase risk for cognitive decline and dementia. Some of these brain changes are thought to reflect actual damage to the small blood vessels that support normal brain function. This clinical trial will determine whether an omega 3 polyunsaturated fatty acid (PUFA) therapy can promote brain health by supporting the small blood vessels in the brain over 3 years in older adults at high risk for cognitive decline and dementia of Alzheimer's type.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- OCT Angiography and NRAI in Dementia#1072911
- Effects of a Colon-delivered Multivitamin Supplement on Brain Functioning, Immunometabolic- and Intestinal Markers in Ageing#887305
- PUFAs and Left Ventricular Function in Heart Failure#918065
- Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly#966585
- Long-term Efficacy and Safety Study of GV-971#846431
Record · ID 911709
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive